ROSEN, NATIONAL TRIAL LAWYERS, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFI

Provided By PR Newswire

Last update: Sep 19, 2023

NEW YORK, Sept. 18, 2023 /PRNewswire/ --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) between January 5, 2022 and July 24, 2023, both dates inclusive (the "Class Period"), of the important October 16, 2023 lead plaintiff deadline.